Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PILL - Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers


PILL - Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers

2025-10-07 12:05:00 ET

By Diederik Stadig

What does the Pfizer-Trump deal cover?

The deal between the Trump Administration and Pfizer (PFE) provides clarity about the near-term future of the US patent-protected pharmaceutical sector after months of (tariff) uncertainty. If companies manufacture and invest in the US, they will be exempt from tariffs. This means that the margin risk from tariffs is largely muted, as branded pharma companies from the US, Europe, and Asia have already announced additional US investments in the next few years....

For further details see:

Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers

Stock Information

Company Name: Direxion Daily Pharmaceutical & Medical Bull 3X Shares
Stock Symbol: PILL
Market: NYSE

Menu

PILL PILL Quote PILL Short PILL News PILL Articles PILL Message Board
Get PILL Alerts

News, Short Squeeze, Breakout and More Instantly...